LifeArc opens search for next CEO
For the past several years, LifeArc has been on a journey of transformative change. As we enter…
LifeArc appoints new chair for neurodegeneration efforts
Today, we're pleased to announce the appointment of Professor Roger Barker as Chair of our neurodegeneration efforts.…
Seven neurodegeneration research projects receive £14.5m from LifeArc-UKDRI partnership
The first projects to be funded through LifeArc’s £30 million strategic partnership with the UK Dementia Research…
LifeArc-funded documentary highlights pioneering scientific research into new targets for treatment of motor neuron disease
A new documentary has been released which follows a key discovery made by researchers at University College…
LifeArc helps fund new research institute to accelerate the search for a cure for MND
A new research institute to accelerate the search for a cure for motor neuron disease (MND, also…
3 LifeArc Ventures’ portfolio companies celebrated in new report on most innovative life science businesses in UK
With the UK setting its sights on becoming a global life sciences superpower, it has created an…
New £30m initiative to address global threat by accelerating the pace of antimicrobial innovation
Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could…
LifeArc welcomes Stéphane Maikovsky as Interim CEO
LifeArc, the self-funded, not-for-profit medical research organisation today announced the appointment of Stéphane Maikovsky as Interim Chief…
LifeArc welcomes new lead and chair to head its Childhood Cancer Translational Challenge
LifeArc welcomes the arrival of a new Translational Challenge Lead, Dr David Jenkinson, and Chair, Professor Andy…